Print

Genetronics Biomedical (GEB) Reports 2004 Financial Results 
10/19/2005 5:13:01 PM

SAN DIEGO--(BUSINESS WIRE)--March 15, 2005--Genetronics Biomedical Corporation (AMEX:GEB) today reported financial results for the quarter and year ended December 31, 2004. Total revenue for the quarter and year ended December 31, 2004, was $542,738 and $1,167,099, respectively, compared to $38,077 and $80,529 for the same periods in 2003. Revenue consisted of license fees, milestone payments, and amounts received from collaborative research and development arrangements and grants.
//-->